Article Listing - Abbott Labs plans cost-cutting, 3,000 job losses as a result of Solvay integration
HOECHST DEFENDS NOMIFENSINE IN SUIT
16 March 1992
The German drugs major Hoechst AG is defending itself against allegations linked to claimed side effects of the company's antidepressant...
ARES-SERONO Rx DRUG SALES UP 15.5%
16 March 1992
On group sales of $751.1 million for the year ended December 31, 1991 (reported in brief last week), Swiss-based Ares-Serono...
MEVACOR WORKS IN FDB, SAYS STUDY
16 March 1992
Familial defective apolipoprotein B-100 (FDB), an autosomal dominant disorder characterized by hyper-cholesterolemia, has been shown to be responsive to treatment...
US ORPHAN DRUG CHANGE "WOULD BE VETOED"
16 March 1992
The US Bush Administration is strongly opposed to S 2060, the Senate legislation which proposes to end the market monopoly...
HANTAREX BIOMED LINK WITH SMA?
16 March 1992
A new alliance with possible developments in the biomedical sector has been set up recently in Italy. Under a preliminary...
LIFEGrOUP CHANGES ACQUISITION PLAN
16 March 1992
After a long period of analysis and negotiation, Italy's LIFEGROUP, founded in 1991, has decided against proceeding with the planned...
BEECHAM WITHDRAWS TALPEN FROM UK
16 March 1992
- Beecham Pharma has withdrawn the broad spectrum penicillin antibiotic Talpen (talampicillin hydrochloride) from the UK market on grounds that...
BBG'S DETECTION KITS
16 March 1992
- British Bio-technology Prod-ucts Ltd has expanded its range of in situ hybridization products to include a Detection Module for...
TREATMENT IND FOR AGOURON'S AG-331
16 March 1992
- Oncologists have confirmed that USA-based Agouron Phar-ma's AG-331 has been effective against tumors in animals. The company plans to...
GENZYME AND GLYCOPROTEINS
16 March 1992
- Genzyme Corp, in collaboration with Robert Van Etten and colleagues at Purdue University, Indiana, has developed technol-ogy which could...
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
